These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 23554040

  • 1. Infliximab-induced discoid lupus erythematosus.
    Cemil BC, Atas H, Canpolat F, Akca Y, Sasmaz R.
    Lupus; 2013 Apr; 22(5):515-8. PubMed ID: 23554040
    [Abstract] [Full Text] [Related]

  • 2. Discoid lupus erythematosus-like eruption induced by infliximab.
    Stratigos AJ, Antoniou C, Stamathioudaki S, Avgerinou G, Tsega A, Katsambas AD.
    Clin Exp Dermatol; 2004 Mar; 29(2):150-3. PubMed ID: 14987271
    [Abstract] [Full Text] [Related]

  • 3. Drug-induced lupus erythematosus in a patient treated with adalumimab.
    Spillane AP, Xia Y, Sniezek PJ.
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S114-6. PubMed ID: 17434034
    [No Abstract] [Full Text] [Related]

  • 4. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY, Browning JC, Larsen F, Hsu S.
    Dermatol Online J; 2008 Sep 15; 14(9):12. PubMed ID: 19061594
    [Abstract] [Full Text] [Related]

  • 5. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors.
    Exarchou SA, Voulgari PV, Markatseli TE, Zioga A, Drosos AA.
    Scand J Rheumatol; 2009 Sep 15; 38(5):328-31. PubMed ID: 19579151
    [Abstract] [Full Text] [Related]

  • 6. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
    Benucci M, Nenci G, Cappelletti C, Manfredi M.
    Recenti Prog Med; 2008 Sep 15; 99(7-8):363-6. PubMed ID: 18751615
    [Abstract] [Full Text] [Related]

  • 7. Anti-TNF-alpha-induced systemic lupus syndrome.
    Debandt M, Vittecoq O, Descamps V, Le Loët X, Meyer O.
    Clin Rheumatol; 2003 Feb 15; 22(1):56-61. PubMed ID: 12605321
    [Abstract] [Full Text] [Related]

  • 8. Cutaneous lupus erythematosus and anti-TNF-alpha therapy: a case report with review of the literature.
    Levine D, Switlyk SA, Gottlieb A.
    J Drugs Dermatol; 2010 Oct 15; 9(10):1283-7. PubMed ID: 20941956
    [Abstract] [Full Text] [Related]

  • 9. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
    van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, Derksen RH, van Roon JA.
    Rheumatology (Oxford); 2006 Oct 15; 45(10):1317-9. PubMed ID: 16844698
    [No Abstract] [Full Text] [Related]

  • 10. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S.
    Int J Rheum Dis; 2009 Jul 15; 12(2):118-24. PubMed ID: 20374328
    [Abstract] [Full Text] [Related]

  • 11. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X, Club Rhumatismes et Inflammation.
    Arthritis Res Ther; 2005 Jul 15; 7(3):R545-51. PubMed ID: 15899041
    [Abstract] [Full Text] [Related]

  • 12. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
    Roux CH, Brocq O, Leccia N, Giacchero D, Breuil V, Albert C, Lacour J, Perrin C, Euller-Ziegler L.
    J Rheumatol; 2007 Feb 15; 34(2):434-7. PubMed ID: 17295430
    [Abstract] [Full Text] [Related]

  • 13. Infliximab treatment of rheumatoid arthritis.
    Maini SR.
    Rheum Dis Clin North Am; 2004 May 15; 30(2):329-47, vii. PubMed ID: 15172044
    [Abstract] [Full Text] [Related]

  • 14. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.
    Kary S, Worm M, Audring H, Huscher D, Renelt M, Sörensen H, Ständer E, Maass U, Lee H, Sterry W, Burmester GR.
    Ann Rheum Dis; 2006 Mar 15; 65(3):405-7. PubMed ID: 16150791
    [Abstract] [Full Text] [Related]

  • 15. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
    Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, Claudepierre P.
    J Rheumatol; 2007 Feb 15; 34(2):380-5. PubMed ID: 17013997
    [Abstract] [Full Text] [Related]

  • 16. Biologic therapy (TNF-alpha antagonists)-induced psoriasis: a cytokine imbalance between TNF-alpha and IFN-alpha?
    Cuchacovich R, Espinoza CG, Virk Z, Espinoza LR.
    J Clin Rheumatol; 2008 Dec 15; 14(6):353-6. PubMed ID: 19033869
    [Abstract] [Full Text] [Related]

  • 17. Differentiating the efficacy of tumor necrosis factor inhibitors.
    Haraoui B.
    J Rheumatol Suppl; 2005 Mar 15; 74():3-7. PubMed ID: 15742457
    [Abstract] [Full Text] [Related]

  • 18. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN.
    Arthritis Rheum; 2000 Nov 15; 43(11):2383-90. PubMed ID: 11083258
    [Abstract] [Full Text] [Related]

  • 19. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A.
    Isr Med Assoc J; 2008 Apr 15; 10(4):277-81. PubMed ID: 18548981
    [Abstract] [Full Text] [Related]

  • 20. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.
    Aghdashi MA, Khadir M, Dinparasti-Saleh R.
    Curr Rheumatol Rev; 2020 Apr 15; 16(1):61-66. PubMed ID: 31057111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.